(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1D mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1601854 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TAF1D mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO RGD:1320067 6480464 ethylene dichloride results in decreased expression of TAF1D mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1320067 6480464 1, 2-Dimethylhydrazine results in decreased expression of TAF1D mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of TAF1D mRNA CTD PMID:17557909 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:1601854 6480464 2 more ... CTD PMID:19095052 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1320067 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to TAF1D promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1320067 6480464 Tetrachlorodibenzodioxin affects the expression of TAF1D mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of TAF1D mRNA CTD PMID:21215274 , PMID:21724226 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of TAF1D mRNA CTD PMID:21346803 2-hydroxypropanoic acid affects expression ISO RGD:1601854 6480464 Lactic Acid affects the expression of TAF1D mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1320067 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of TAF1D mRNA CTD PMID:18648102 4-hydroxyphenyl retinamide increases expression ISO RGD:1320067 6480464 Fenretinide results in increased expression of TAF1D mRNA CTD PMID:28973697 aflatoxin M1 decreases expression ISO RGD:1601854 6480464 Aflatoxin M1 results in decreased expression of TAF1D mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO RGD:1320067 6480464 Tretinoin results in decreased expression of TAF1D mRNA CTD PMID:16604517 arsane decreases expression ISO RGD:1601854 6480464 Arsenic results in decreased expression of TAF1D mRNA CTD PMID:16835338 arsenic atom decreases expression ISO RGD:1601854 6480464 Arsenic results in decreased expression of TAF1D mRNA CTD PMID:16835338 arsenous acid increases expression ISO RGD:1601854 6480464 Arsenic Trioxide results in increased expression of TAF1D mRNA CTD PMID:22521957 benzo[a]pyrene increases expression ISO RGD:1320067 6480464 Benzo(a)pyrene results in increased expression of TAF1D mRNA CTD PMID:19770486 , PMID:22228805 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of TAF1D mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TAF1D mRNA CTD PMID:30816183 bisphenol A affects expression ISO RGD:1601854 6480464 bisphenol A affects the expression of TAF1D mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1601854 6480464 bisphenol A results in decreased expression of TAF1D mRNA CTD PMID:29275510 cadmium dichloride decreases expression ISO RGD:1320067 6480464 Cadmium Chloride results in decreased expression of TAF1D mRNA CTD PMID:20883709 cadmium dichloride increases expression ISO RGD:1601854 6480464 Cadmium Chloride results in increased expression of TAF1D mRNA CTD PMID:21457566 , PMID:26472689 cadmium dichloride increases methylation EXP 6480464 Cadmium Chloride results in increased methylation of TAF1D promoter CTD PMID:22457795 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of TAF1D mRNA CTD PMID:20864626 carbamazepine affects expression ISO RGD:1601854 6480464 Carbamazepine affects the expression of TAF1D mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1320067 6480464 Nanotubes, Carbon analog results in increased expression of TAF1D mRNA, Nanotubes, Carbon results in increased expression of TAF1D mRNA CTD PMID:25554681 , PMID:25620056 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of TAF1D mRNA CTD PMID:23125180 chromium(6+) affects expression ISO RGD:1320067 6480464 chromium hexavalent ion affects the expression of TAF1D mRNA CTD PMID:28472532 chromium(6+) increases expression ISO RGD:1601854 6480464 chromium hexavalent ion results in increased expression of TAF1D mRNA CTD PMID:30690063 cisplatin decreases expression ISO RGD:1601854 6480464 Cisplatin results in decreased expression of TAF1D mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1601854 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of TAF1D mRNA CTD PMID:27392435 cobalt dichloride increases expression ISO RGD:1601854 6480464 cobaltous chloride results in increased expression of TAF1D mRNA CTD PMID:19376846 copper atom increases expression EXP 6480464 Copper results in increased expression of TAF1D mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of TAF1D mRNA CTD PMID:30556269 cyclosporin A increases expression ISO RGD:1601854 6480464 Cyclosporine results in increased expression of TAF1D mRNA CTD PMID:20106945 more ... DDT increases expression ISO RGD:1601854 6480464 DDT results in increased expression of TAF1D mRNA CTD PMID:25014179 diarsenic trioxide increases expression ISO RGD:1601854 6480464 Arsenic Trioxide results in increased expression of TAF1D mRNA CTD PMID:22521957 dibutyl phthalate decreases expression ISO RGD:1320067 6480464 Dibutyl Phthalate results in decreased expression of TAF1D mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of TAF1D mRNA CTD PMID:21266533 dicrotophos decreases expression ISO RGD:1601854 6480464 dicrotophos results in decreased expression of TAF1D mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1601854 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 fluoranthene multiple interactions ISO RGD:1320067 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of TAF1D mRNA CTD PMID:28329830 glafenine increases expression EXP 6480464 Glafenine results in increased expression of TAF1D mRNA CTD PMID:24136188 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of TAF1D mRNA CTD PMID:26302742 leflunomide decreases expression ISO RGD:1320067 6480464 leflunomide results in decreased expression of TAF1D mRNA CTD PMID:19751817 leflunomide increases expression ISO RGD:1601854 6480464 leflunomide results in increased expression of TAF1D mRNA CTD PMID:28988120 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of TAF1D mRNA CTD PMID:30467583 methoxyacetic acid decreases expression EXP 6480464 methoxyacetic acid results in decreased expression of TAF1D mRNA CTD PMID:20864626 methyl methanesulfonate increases expression ISO RGD:1601854 6480464 Methyl Methanesulfonate results in increased expression of TAF1D mRNA CTD PMID:23649840 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of TAF1D mRNA CTD PMID:20864626 methylmercury chloride decreases expression ISO RGD:1601854 6480464 methylmercuric chloride results in decreased expression of TAF1D mRNA CTD PMID:28001369 methylmercury chloride increases expression ISO RGD:1601854 6480464 methylmercuric chloride results in increased expression of TAF1D mRNA CTD PMID:28001369 methylparaben increases expression ISO RGD:1601854 6480464 methylparaben results in increased expression of TAF1D mRNA CTD PMID:31745603 Monobutylphthalate decreases expression EXP 6480464 monobutyl phthalate results in decreased expression of TAF1D mRNA CTD PMID:20864626 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TAF1D mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of TAF1D mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1320067 6480464 Acetaminophen affects the expression of TAF1D mRNA CTD PMID:17562736 phenobarbital affects expression ISO RGD:1601854 6480464 Phenobarbital affects the expression of TAF1D mRNA CTD PMID:19159669 pirinixic acid increases expression ISO RGD:1320067 6480464 pirinixic acid results in increased expression of TAF1D mRNA CTD PMID:23811191 potassium chromate multiple interactions ISO RGD:1601854 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of TAF1D mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:1601854 6480464 potassium chromate(VI) results in increased expression of TAF1D mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1320067 6480464 Pregnenolone Carbonitrile results in increased expression of TAF1D mRNA CTD PMID:28903501 rac-lactic acid affects expression ISO RGD:1601854 6480464 Lactic Acid affects the expression of TAF1D mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1601854 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1320067 6480464 Silicon Dioxide results in decreased expression of TAF1D mRNA CTD PMID:19073995 silver atom increases expression ISO RGD:1320067 6480464 Silver results in increased expression of TAF1D mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1320067 6480464 Silver results in increased expression of TAF1D mRNA CTD PMID:27131904 sodium arsenate decreases expression ISO RGD:1320067 6480464 sodium arsenate results in decreased expression of TAF1D mRNA CTD PMID:30953684 sodium arsenite decreases expression ISO RGD:1601854 6480464 sodium arsenite results in decreased expression of TAF1D mRNA CTD PMID:28595984 sodium arsenite decreases expression ISO RGD:1320067 6480464 sodium arsenite results in decreased expression of TAF1D mRNA CTD PMID:20883709 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of TAF1D mRNA CTD PMID:22110744 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of TAF1D mRNA CTD PMID:25993096 sodium dichromate increases expression ISO RGD:1601854 6480464 sodium bichromate results in increased expression of TAF1D mRNA CTD PMID:17685462 sodium fluoride decreases expression ISO RGD:1320067 6480464 Sodium Fluoride results in decreased expression of TAF1D mRNA CTD PMID:27862939 succimer multiple interactions ISO RGD:1320067 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF1D mRNA CTD PMID:21641980 tetrachloromethane increases expression ISO RGD:1320067 6480464 Carbon Tetrachloride results in increased expression of TAF1D mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of TAF1D mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of TAF1D mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of TAF1D mRNA CTD PMID:23411599 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of TAF1D mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of TAF1D mRNA CTD PMID:25729387 trichostatin A increases expression ISO RGD:1601854 6480464 trichostatin A results in increased expression of TAF1D mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1601854 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF1D mRNA CTD PMID:27188386 tungsten increases expression ISO RGD:1320067 6480464 Tungsten results in increased expression of TAF1D mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1320067 6480464 Valproic Acid affects the expression of TAF1D mRNA CTD PMID:17963808 valproic acid multiple interactions ISO RGD:1601854 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TAF1D mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1601854 6480464 Valproic Acid results in decreased expression of TAF1D mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:1601854 6480464 Valproic Acid results in increased expression of TAF1D mRNA CTD PMID:26272509 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of TAF1D mRNA CTD PMID:23034163 , PMID:23555832 vincristine decreases expression ISO RGD:1601854 6480464 Vincristine results in decreased expression of TAF1D mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:1601854 6480464 Vitamin E results in decreased expression of TAF1D mRNA CTD PMID:19244175 
Gene-Chemical Interaction Annotations
